The role of alkamides as an active principle of Echinacea

Planta Medica

Volumn 73, Issue 7, 2007, Pages 615-623

  Woelkart, Karin ^a   Bauer, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Alkamides; Asteraceae; Cannabinoid receptor binding; Echinacea angustifolia; Echinacea purpurea; Herb drug interactions; Immunomodulation; Pharmacokinetics

Indexed keywords

ANANDAMIDE; CANNABINOID 2 RECEPTOR; CYTOCHROME P450; DODECA 2 ENE 8,10 DIYNOIC ACID 2 METHYLBUTYLAMIDE; DODECA 2,4 DIENE 8,10 DIYNOIC ACID 2 METHYLBUTYLAMIDE; DODECA 2,4 DIENOIC ACID ISOBUTYLAMIDE; DODECA 2,4,10 TRIENE 8 YNOIC ACID ISOBUTYLAMIDE; DODECA 2,4,8 TRIENOIC ACID ISOBUTYLAMIDE; DODECA 2,4,8,10 TETRAENOIC ACID ISOBUTYLAMIDE; ECHINACEA ANGUSTIFLORA EXTRACT; ECHINACEA PALLIDA EXTRACT; ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; ECHINILIN; PENTADECA 2,9 DIENE 12,14 DIYNOIC ACID ISOBUTYLAMIDE; TETRADECA 2 ENE 10,12 DIYNOIC ACID ISOBUTYLAMIDE; UNCLASSIFIED DRUG; UNDECA 2,4 DIENE 8,10 DIYNOIC ACID ISOBUTYLAMIDE;

BINDING AFFINITY; CLINICAL TRIAL; COMMON COLD; DISEASE DURATION; DISEASE SEVERITY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; ECHINACEA; ENZYME ACTIVITY; ENZYME METABOLISM; HERB DRUG INTERACTION; HUMAN; IN VIVO STUDY; NONHUMAN; SHORT SURVEY;

ADMINISTRATION, ORAL; ECHINACEA; HERB-DRUG INTERACTIONS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID;

ASTERACEAE; ECHINACEA (ASTERACEAE); ECHINACEA ANGUSTIFOLIA; ECHINACEA PURPUREA;

EID: 34447500693     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981531     Document Type: Short Survey

References (48)

1. Brevoort T. The booming U.S. botanical market. Herbalgram 1998; 44: 33-46.
2. Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2003; 10: 66-86.
3. Linde K, Barrett B, Woelkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2006; Issue 1.
4. Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): A review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2005; 57: 929-54.
5. Bauer R. Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In: Wagner H, editor. Immunomodulatory agents from plants. Basel, Boston, Berlin: Birkhauser Verlag; 1999: 41-88.
6. Greger H. Comparative phytochemistry of the alkamides. Amsterdam, Oxford, New York, Tokyo: Elsevier; 1988.
7. Breyant BP, Mezine I. Alkylamides that produce tingling paresthesia activate tactile and thermal trigeminal neurons. Brain Res 1999; 842: 452-60.
8. Ramsewak RS, Erickson AJ, Nair MG. Bioactive N-isobutylamides from the flower buds of Spilanthes acmella. Phytochemistry 1999; 51: 729-32.
9. Bohlmann R, Ziesche J, Robinson H, King RM. Polyacetylene compounds - new amides from Spilanthes alba. Phytochemistry 1980; 19: 1535-7.
10. Perry NB, Van Klink JW, Burgess EJ, Parmenter GA. Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers. Planta Med 1997; 63: 58-62.
11. Bauer R, Remiger P, Wagner H. Echinacea. Vergleichende DC- und HPLC-Analyse der Herba-Drogen von Echinacea purpurea, E. pallida und E. angustifolia. Dtsch Apoth Ztg 1988; 128: 174-80.
12. Kabganian R, Carrier DJ, Rose PA, Abrams SR, Sokhansanj S. Localization of alkamides, echinacoside and cynarin with Echinacea angustifolia. J Herbs Spices Med Plants 2002; 10: 73-81.
13. Wills RBH, Stuart DL. Alkylamide and cichoric acid levels in Echinacea purpurea grown in Australia. Food Chem 1999; 67: 385-8.
14. 2 and multiple signal transduction pathways. FEBS Lett 2004; 577: 563-9.
15. Woelkart K, Marth E, Raggam R, Suter A, Schoop R, Koidl C et al. Bioavailability and pharmacokinetic studies on Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharm Ther 2006; 44: 401-8.
16. 2-receptor dependent and independent immunomodulatory effects. J Biol Chem 2006; 281: 14192-206.
17. Bauer R, Jurcic K, Puhlmann J, Wagner H. Immunologische in vivo- und in vitro-Untersuchungen mit Echinacea Extrakten [Immunological studies in vivo and in vitro of Echinacea extracts. Translated by Beate V Foit, Santa Cruz, CA, USA]. Arzneimittelforschung/Drug Res 1988; 38: 276-81.
18. Bauer R, Remiger P, Jurcic K, Wagner H. Beeinflussung der Phagozytose-Aktivität durch Echiancea-Extrakte [Influence of Echinacea extract on phagocytotic activity. Reviewed in translation, translator unknown]. ZPhytother 1989; 10: 43-8.
19. Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukocyte Biol 2000; 68: 503-10.
20. Bauer R, Jurcic K, Puhlmann J, Wagner H. Immunologische in vivo- und in vitro-Untersuchungen mit Echinacea-Extrakten. Arzneimittelforschung 1988; 38: 276-81.
21. Bauer R, Remiger P, Jurcic K, Wagner H. Beeinflussung der Phagozytose-Aktivität durch Echinacea-Extrakte. Z Phytother 1989; 10: 43-8.
22. Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R et al. Echinacea stimulates macrophage function in the lung and spleen of normal rats. J Nutr Biochem 2002; 13: 487-92.
23. Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol 2002; 2: 381-7.
24. Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M et al. Macrophage activating effects of new alkamides from the roots of Echinacea Species. J Nat Prod 2005; 68: 773-6.
25. Stevenson LM, Matthias A, Banbury L, Penman KG, Bone KM, Leach D et al. Modulation of macrophage immune responses by Echinacea. Molecules 2005; 10: 1279-85.
26. Clifford LJ, Nair MG, Rana J, Dewitt DL. Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench. Phytomedicine 2002; 9: 249-53.
27. Müller-Jakic B, Breu W, Pröbstle A, Redl K, Greger H, Bauer R. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med 1994; 60: 37-40.
28. Merali S, Binns S, Paulin-Levasseur M, Ficker C, Smith M, Baum B et al. Antifungal and anti-inflammatory activity of the genus Echinacea. Pharm Biol 2003; 41: 412-20.
29. Hinz B, Woelkart K, Bauer R. Alkamides from Echinacea inhibit cyclooxygenase-2-dependent prostaglandin synthesis in human neuroglioma cells. Planta Med 2006; 72: 1062.
30. Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med 2005; 71: 701-5.
31. Sasagawa M, Cech NB, Gray D, Elmer GW, Wenner CA. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells. Int Immunopharmacol 2006; 6: 1214-21.
32. Hudson J, Vimalanathan S, Kang L, Amiguet VT, Livesey J, Arnason JT. Characterization of antiviral activities in Echinacea root preparations. Pharm Biol 2005; 43: 790-6.
33. Goel V, Lovlin R, Chang C, Slama JV, Barton R, Gahler R et al. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold. Phytother Res 2005; 19: 689-94.
34. Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TDG et al. Efficacy of a standardized Echinacea preparation (Echinilin™) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 2004; 29: 75-83.
35. Barton R. Efficacy of echinilin for the common cold. Clin Infect Dis 2005; 41: 761-2.
36. Dietz B, Heilmann J, Bauer R. Absorption of dodeca-2E,4E, 8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture. Planta Med 2001; 67: 863-4.
37. Jager H, Meinel L, Dietz B, Lapke C, Bauer R, Merkle HP et al. Transport of alkamides from Echinacea species through Caco-2 monolayers. Planta Med 2002; 68: 469-71.
38. Matthias A, Blanchfield JT, Penman KG, Toth I, Lang CS, De Voss JJ et al. Permeability studies of alkylamides and caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer model. J Clin Pharm Ther 2004; 29: 7-13.
39. Woelkart K, Koidl C, Grisold A, Gangemi JD, Turner RB, Marth E et al. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans. J Clin Pharmacol 2005; 45: 683-9.
40. Matthias A, Addison RS, Penman KG, Dickinson RG, Bone KM, Lehmann RP. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci 2005; 77: 2018-29.
41. Osowski S. Echinacea - ein Immunstimulans? Zur Pharmakokinetik der Echinacea purpurea-Inhaltsstoffe Dodeca-2E,4E,8Z,10E/Z-tetraensäure- isobutylamid und Cichoriensäure sowie ihr immunmodulierender Einfluss. [dissertation]. Freiburg: Albert Ludwig University; 1998.
42. Butterweck V, Derendorf H, Gaus W, Nahrstedt A, Schulz V, Unger M. Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?. Planta Med 2004; 70: 784-91.
43. Matthias A, Gillam EMJ, Penman KG, Matovis NJ, Bone KM, De Voss JJ et al. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem Biol Interact 2005; 155: 62-70.
44. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004; 76: 428-40.
45. Gorski JC, Huang S-M, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA et al. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004; 75: 89-100.
46. Yale SH, Glurich I. Analysis of the inhibitory potential of Ginkgo biloba. Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2 C9. J Altern Complement Med 2005; 11: 433-9.
47. Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005; 353: 341-8.
48. Blumenthal M, Farnsworth NR, Leach M, Turner RB, Gangemi JD. Echinacea angustifolia in rhinovirus infections (multiple letters). N Engl J Med 2005; 353: 1971-2.